U.S. Stock Earnings Reports & Market News
Executive Summary In the third quarter of fiscal year 2025, Linkhome Holdings Inc. demonstrated significant revenue growth, with a 162% increase compared to the same period last year, driven by expanding operations and market penetration. Despite this growth, the company…
Executive Summary U.S. GoldMining Inc (NASDAQ: USGO) reported its third quarter fiscal 2025 financial results, demonstrating a significant reduction in net loss by 35.0% compared to the same period last year, with a net loss of $2.81 million versus $4.34…
Executive Summary Falcon’s Beyond Global Inc (FBYD) reported its fiscal third quarter of 2025 with a significant revenue growth of 26% compared to the same period last year, driven by increased sales across its segments. Despite ongoing operational challenges and…
Executive Summary This report provides a comprehensive analysis of Klotho Neurosciences, Inc. (KLTO) for the third quarter of fiscal year 2025. The company reported a net loss of $2,959,426, representing a significant decrease compared to the prior year’s net loss…
Executive Summary In the third quarter of 2025, NVVE reported a significant decline in revenue, decreasing by 16.4% compared to the previous year, primarily driven by lower sales volumes and market headwinds. The company posted a net loss of $4.79…
Executive Summary Serve Robotics Inc., traded on NASDAQ under the ticker SERV, reported its financial results for the third quarter of fiscal year 2025. The company experienced a significant increase in revenue, driven by growth in fleet and software services,…
Executive Summary BioAtla Inc (NASDAQ: BCAB) reported its Q3 2025 financial results, showing a significant reduction in net loss compared to the same period last year, decreasing by approximately 28.4%. The company’s strategic focus on cost control and pipeline development…
Executive Summary In the third quarter of fiscal year 2025, Society Pass Incorporated reported a significant decline in revenue and net income compared to the previous year. Revenue decreased by 17.7% from $2,058,264 in Q3 2024 to $1,380,382 in Q3…
Executive Summary In the third quarter of fiscal year 2025, TMC the metals Co Inc. reported a net loss of $184.5 million, representing a 794% increase compared to a net loss of $20.5 million in the same period last year.…
Executive Summary Neve Yarak Inc, trading under the symbol NITO on NASDAQ, reported its Q3 FY2025 financials with a significant surge in net loss, increasing by approximately 5395% compared to the prior year. The company’s net loss widened from $-2.3…
Executive Summary In the third quarter of fiscal year 2025, CISO Global Inc demonstrated significant revenue growth, with total revenue reaching approximately $6.46 million, representing a 26% increase compared to the same period last year. Despite ongoing operational expenses and…
Key Metrics Metric Q3 2025 Q2 2025 Change Revenue $150 million $103 million 45.2% increase Net Income $12 million $8 million 50.0% increase Gross Profit $60 million $42 million 42.9% increase Total Assets $500 million $480 million 4.2% increase Executive…
Executive Summary Reviva Pharmaceuticals Holdings Inc (RVPH) reported its Q3 FY2024 financial results, revealing a significant reduction in net loss compared to the previous year. The company’s net loss decreased by approximately 20.4%, from $10.49 million in Q3 FY2023 to…
Executive Summary Virgin Galactic Holdings Inc (SPCE) reported a significant increase in revenue for the third quarter of 2025, driven by higher ticket sales and expanded flight operations. Despite ongoing investments in technology and infrastructure, the company demonstrated improved liquidity…
Executive Summary Wrap Technologies Inc, trading under the ticker WRAP, reported its fiscal third quarter of 2025 with a remarkable surge in revenue and a substantial reduction in net loss compared to the same period last year. The company’s revenue…
Executive Summary In the third quarter of fiscal year 2025, Spero Therapeutics Inc. demonstrated a robust revenue growth of 26% compared to the same period last year, driven primarily by increased collaboration and grant revenues. Despite ongoing R&D investments and…
Executive Summary GRAIL Inc, a leading healthcare innovator specializing in early cancer detection, reported its financial results for the third quarter of fiscal year 2025. The company demonstrated robust growth with total revenue increasing by 26% compared to the same…
Executive Summary Q32 Bio Inc., a leading clinical-stage biotechnology company focused on autoimmune and inflammatory diseases, reported its financial results for the third quarter of FY2025. The company experienced a significant increase in net loss, primarily driven by elevated research…
Executive Summary In the third quarter of fiscal year 2025, Moleculin Biotech Inc (NASDAQ: MBRX) reported a net loss of $25.4 million, representing a 49.4% increase from the $17.0 million net loss in the same period last year. The company’s…
Executive Summary Iterum Therapeutics plc, trading under the ticker ITRM on NASDAQ, reported its Q3 FY2025 financial results. The company’s net loss decreased by approximately 11.4% compared to the same period last year, reflecting improved cost management and operational adjustments…
Executive Summary Actuate Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing therapies for cancer, reported its financial results for the third quarter of fiscal year 2025. The company experienced a significant increase in net loss, which grew by approximately…
Executive Summary Elicio Therapeutics, Inc. (NASDAQ: ELTX) reported its financial results for the third quarter of fiscal year 2025. The company experienced a significant increase in net loss, which grew by approximately 46.4% compared to the same period last year,…
Executive Summary Contango Ore Inc. (CTGO) reported its fiscal third quarter of 2025, demonstrating significant growth in revenue driven by the operational ramp-up of its flagship Manh Choh gold project. The company’s revenue surged by approximately 26.4% compared to the…
Executive Summary Precigen Inc (NASDAQ: PGEN) reported its third quarter of FY2025, reflecting significant operational and financial adjustments following the FDA approval of Papzimeos. The company’s net loss decreased by 39.2% year-over-year, primarily driven by reduced research and development expenses…
Executive Summary TechPrecision Corporation reported its third quarter of fiscal year 2025 with a net loss of $799,000, representing a slight decrease compared to the net loss of $865,334 in the same period last year. Revenue remained relatively stable at…
Executive Summary For the third quarter of fiscal year 2025, TSS Inc. reported a significant decline in revenue, decreasing by 40.2% compared to the same period last year, primarily driven by a reduction in procurement services revenue. The company posted…
Executive Summary Neuphoria Therapeutics Inc. reported a remarkable financial turnaround in Q3 FY2025, driven primarily by a substantial increase in revenue and net income compared to the previous year. The company’s revenue surged from zero in Q3 FY2024 to $15…
Executive Summary In the third quarter of fiscal year 2025, Marker Therapeutics, Inc. reported a net loss of $1,998,662, representing a 13.1% decrease compared to the prior year’s net loss of $2,701,692. The company’s cash position increased significantly to $17,592,978…
Executive Summary Red Cat Holdings Inc (RCAT) reported its third quarter FY2025 results, revealing a significant decline in net income compared to the previous year. The company posted a net loss of $5.49 million, a decrease of approximately 3.4% from…
Executive Summary NIQ, a leading global consumer intelligence company, reported its fiscal third quarter of 2025 with total revenues of $1.052 billion, representing a 7.2% increase compared to $982.1 million in the same period last year. The company’s net loss…